Echocardiographic predictors of progression from prehypertension to hypertension

Dogan Erdogan1, Mehmet Ozaydin, Atilla Icli

  • 1Faculty of Medicine, Cardiology Department, Suleyman Demirel University, Isparta, Turkey. aydoganer@yahoo.com

Insights

Prehypertension can progress to hypertension. Key predictors include systolic blood pressure, metabolic syndrome, HDL cholesterol, microalbuminuria, and coronary flow reserve (CFR).

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diagnostic Markers

Background:

  • Prehypertension (PHT) signifies elevated cardiovascular risk and potential progression to hypertension (HT).
  • Identifying individuals with PHT at high risk for developing HT remains a clinical challenge.
  • This study sought to identify echocardiographic predictors for PHT to HT progression.

Purpose of the Study:

  • To establish echocardiographic predictors of progression from prehypertension to hypertension.
  • To identify specific markers that indicate a high risk of developing hypertension in prehypertensive individuals.

Main Methods:

  • A prospective study involving 98 prehypertensive patients.
  • Baseline echocardiographic examinations, including coronary flow reserve (CFR), were performed.
  • Patients were followed for 3 years to monitor the development of hypertension.

Main Results:

  • Twenty-nine percent of participants developed hypertension within 3 years.
  • Significant independent predictors for HT progression included baseline systolic blood pressure (SBP), metabolic syndrome, high-density lipoprotein (HDL) cholesterol, microalbuminuria, and CFR.
  • Coronary flow reserve (CFR) demonstrated a cutoff value of 1.98 for predicting incident HT with high sensitivity and specificity.

Conclusions:

  • Baseline SBP, metabolic syndrome, HDL cholesterol, microalbuminuria, and CFR are significant independent markers for predicting HT development in PHT patients.
  • Echocardiographic markers, particularly CFR reflecting coronary microvascular function, are valuable in risk stratification.
  • Left ventricular diastolic function parameters were not significant predictors in this cohort.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...